Enprofylline--effects of a new bronchodilating xanthine derivative in asthmatic patients. 1983

L C Laursen, and N Johannesson, and A Dirksen, and R Djurup, and E P Munch, and E Taudorf, and B Weeke

The bronchodilating effect of two doses of peroral enprofylline was compared with placebo in 24 asthmatic patients. Enprofylline produced significantly greater bronchodilatation than placebo. A dose of 2 mg/kg b.wt. and 4 mg/kg b.wt. caused a mean maximal increase in FEV1 of 26% and 35%, respectively. The degree and the incidence of headache and nausea were estimated by means of a scoring system. Dose-related effects on both parameters were observed. Other side effects were negligible. In seven patients the mean plasma half-life of enprofylline was found to be 113 min. It is suggested that enprofylline should be studied further in patients suffering from obstructive lung disease.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse

Related Publications

L C Laursen, and N Johannesson, and A Dirksen, and R Djurup, and E P Munch, and E Taudorf, and B Weeke
July 1983, European journal of respiratory diseases,
L C Laursen, and N Johannesson, and A Dirksen, and R Djurup, and E P Munch, and E Taudorf, and B Weeke
August 1987, Annals of allergy,
L C Laursen, and N Johannesson, and A Dirksen, and R Djurup, and E P Munch, and E Taudorf, and B Weeke
December 1987, Danish medical bulletin,
L C Laursen, and N Johannesson, and A Dirksen, and R Djurup, and E P Munch, and E Taudorf, and B Weeke
October 1981, Acta pharmacologica et toxicologica,
L C Laursen, and N Johannesson, and A Dirksen, and R Djurup, and E P Munch, and E Taudorf, and B Weeke
April 1987, American journal of obstetrics and gynecology,
L C Laursen, and N Johannesson, and A Dirksen, and R Djurup, and E P Munch, and E Taudorf, and B Weeke
July 1996, The Journal of pharmacy and pharmacology,
L C Laursen, and N Johannesson, and A Dirksen, and R Djurup, and E P Munch, and E Taudorf, and B Weeke
January 1972, Ftiziologia,
L C Laursen, and N Johannesson, and A Dirksen, and R Djurup, and E P Munch, and E Taudorf, and B Weeke
August 1965, Therapeutische Umschau. Revue therapeutique,
L C Laursen, and N Johannesson, and A Dirksen, and R Djurup, and E P Munch, and E Taudorf, and B Weeke
March 1986, Acta pharmacologica et toxicologica,
L C Laursen, and N Johannesson, and A Dirksen, and R Djurup, and E P Munch, and E Taudorf, and B Weeke
January 1982, European journal of clinical pharmacology,
Copied contents to your clipboard!